Single Dose Liposomal Amphotericin for Asymptomatic Cryptococcal Antigenemia
Single Dose Liposomal Amphotericin for Asymptomatic Cryptococcal Antigenemia
Recruiting · NCT03945448 · Registry updated 2026-04-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Single Dose Liposomal Amphotericin for Asymptomatic Cryptococcal Antigenemia | Bacterial Infections and Mycoses, Central Nervous System Fungal Infections, Cryptococcal meningitis, Infections, Neuroinflammatory Diseases, central nervous system disorder, central nervous system infectious disorder, cryptococcosis, fungal infectious disease, fungal meningitis, meningitis, nervous system disorder | Recruiting | Phase 2 / Phase 3 | 2026-04-28 | NCT03945448 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Gilead Sciences | 180 |
| Makerere University | 49 |
| University of Minnesota | 344 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| infectious Disease Institute Kampala,Uganda | Kampala | Uganda | 1 |